Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Primary Open Angle Glaucoma
NCT04155164Unknown
- Sponsor
- Zhongshan Ophthalmic Center
- Start
- Dec 2019
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in primary open-angle glaucoma (POAG) comparing Metformin with Placebo (2 arms). Primary endpoint: Visual field at 12 months. Status: unknown.
02
Drugs
metformin
03
Conditions
primary open-angle glaucoma (POAG)
Beyond the preview
Go deeper on NCT04155164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04155164.